EP 4164605 A1 20230419 - METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH FINGOLIMOD, A SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATOR, AND DERIVATIVES THEREOF
Title (en)
METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH FINGOLIMOD, A SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATOR, AND DERIVATIVES THEREOF
Title (de)
VERFAHREN UND ZUSAMMENSETZUNGEN ZUR PRÄVENTION UND BEHANDLUNG VON MYOPIE MIT FINGOLIMOD, EINEM SPHINGOSIN-1-PHOSPHAT-REZEPTORMODULATOR UND DERIVATEN DAVON
Title (fr)
PROCÉDÉS ET COMPOSITIONS POUR LA PRÉVENTION ET LE TRAITEMENT DE LA MYOPIE AVEC DU FINGOLIMOD, UN MODULATEUR DU RÉCEPTEUR DE LA SPHINGOSINE-1-PHOSPHATE ET DÉRIVÉS DE CELLE-CI
Publication
Application
Priority
- US 202063037910 P 20200611
- US 2021036628 W 20210609
Abstract (en)
[origin: WO2021252636A1] The disclosure relates to methods and compositions for preventing and/or treating an ocular disease. In particular, the disclosure relates to preventing and/or treating myopia with systemic or topical administration of fingolimod phosphate, which is a sphingosine-1- phosphate receptor modulator, or a derivative thereof.
IPC 8 full level
A61K 9/00 (2006.01); A61K 31/661 (2006.01); A61P 27/10 (2006.01)
CPC (source: EP IL KR)
A61K 9/0048 (2013.01 - EP IL KR); A61K 31/661 (2013.01 - EP IL KR); A61P 27/10 (2018.01 - EP IL KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021252636 A1 20211216; CA 3182431 A1 20211216; CN 116133665 A 20230516; EP 4164605 A1 20230419; IL 298996 A 20230201; JP 2023530681 A 20230719; KR 20230051154 A 20230417
DOCDB simple family (application)
US 2021036628 W 20210609; CA 3182431 A 20210609; CN 202180058323 A 20210609; EP 21821401 A 20210609; IL 29899622 A 20221211; JP 2022576467 A 20210609; KR 20237001145 A 20210609